title: Adjuvant chemotherapy following cystectomy benefits patients with deeply invasive bladder cancer.
authors.affiliation: Department of Urology, Kenneth Norris Jr Cancer Hospital and Research Institute, University of Southern California School of Medicine, Los Angeles 90033.
authors.forename: D G
authors.initials: DG
authors.lastname: Skinner
authors.forename: J R
authors.initials: JR
authors.lastname: Daniels
authors.forename: C A
authors.initials: CA
authors.lastname: Russell
authors.forename: G
authors.initials: G
authors.lastname: Lieskovsky
authors.forename: S D
authors.initials: SD
authors.lastname: Boyd
authors.forename: M
authors.initials: M
authors.lastname: Krailo
authors.forename: S
authors.initials: S
authors.lastname: Groshen
mesh_terms: D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D003131:Combined Modality Therapy; D015653:Cystectomy; D006801:Humans; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery